An open-label extension of Study M15-741 to evaluate the safety and tolerability of 24-hour daily exposure of continuous subcutaneous infusion of ABBV-951 in subjects with Parkinson's disease. CTMS#: 20-0108
Lay Description
Category
- Nervous System
- IRB Number
- 20200585HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Sarah Martinez
(210) 450-0569
martinezs23@uthscsa.edu
Charlotte Rhodes
(210) 450-8454
rhodesc1@uthscsa.edu
Eleni Okeanis Vaou
(210) 450-8048
vaou@uthscsa.edu
Sarah Martinez
(210) 450-0569
martinezs23@uthscsa.edu
Charlotte Rhodes
(210) 450-8454
rhodesc1@uthscsa.edu
Eleni Okeanis Vaou
(210) 450-8048
vaou@uthscsa.edu
Principal Investigator
Eleni Okeanis Vaou